Endocrine Health in LGBTQ+ Populations

Endocrine health in LGBTQ+ populations encompasses the unique healthcare needs and disparities faced by individuals who identify as lesbian, gay, bisexual, transgender, queer, or other sexual and gender minorities. Hormonal transitions associated with gender-affirming care, including hormone therapy and surgical interventions, require specialized management tailored to individual preferences and goals. Access to affirming and culturally competent healthcare services is essential for addressing hormone-related concerns and promoting endocrine health in LGBTQ+ communities. Moreover, awareness of the impact of societal stigma, discrimination, and minority stress on endocrine health underscores the importance of holistic approaches to care that address social determinants of health and promote health equity for LGBTQ+ individuals.

    Related Conference of Endocrine Health in LGBTQ+ Populations

    September 09-10, 2024

    7th Annual Meeting on Diabetes and Endocrinology

    Paris, France
    September 09-10, 2024

    4th European Endocrinology and Diabetes Congress

    Paris, France
    September 09-10, 2024

    33rd International Diabetes and Healthcare Conference

    Paris, France
    September 25-26, 2024

    5th World Summit on Diabetes Expo

    Rome, Italy
    October 14-15, 2024

    3rd International Summit on Hormonal Disorders

    Madrid, Spain
    November 22-23, 2024

    20th World Congress on Endocrinology & Diabetes

    Amsterdam, Netherlands
    February 24-25, 2025

    34th European Diabetes Congress

    London, UK

    Endocrine Health in LGBTQ+ Populations Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in